# INRA

> INRA is a VC fund in Paris backing Biopharma and Health Care. See 2 investments, round sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Paris, France
- Total investments: 2
- Last investment: Jul 2018
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/french-national-institute-for-agricultural-research
- X (Twitter): https://twitter.com/Inra_Intl
- Website: http://www.inra.fr/
- Facebook: https://www.facebook.com/255779403738

INRA is a VC fund in Paris focused on Biopharma and Health Care. INRA is Europe’s top agricultural research institute and the world’s number two centre for the agricultural sciences. Its scientists are working towards solutions for society’s major challenges.

## Contacts

5 contacts available for INRA. Shizune tracks 2 team members at INRA. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/inra-2?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biopharma | 2 | 100% |
| Health Care | 2 | 100% |
| Biotechnology | 2 | 100% |
| Life Science | 1 | 50% |
| Pharmaceutical | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Series A | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Evelyne Lhoste | Team Member | 0 | https://shizune.co/investors/profile/evelyne-lhoste |
| Joel Dore | Research Director | 0 | https://shizune.co/investors/profile/joel-dore |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Exeliom | Exeliom is a clinical-stage biopharmaceutical company tackling the use of commensal bacteria as drugs. Their mission is to harness the therapeutic potential of gut microbiota to enable people to lead longer and healthier lives. They are committed to developing the next generation of probiotics: innovative microbial therapies.Exeliom develops anew class of medicines called Live Biotherapeutics based on their growing understanding of the central role of the microbiota in the immune system.The company was founded in 2016 and is headquartered in Dijon, France. | $7.7M | Series A | Jul 06, 2018 | https://www.exeliombio.com |
| ENTEROME | Enterome is an integrated company leveraging its unique knowledge of the key functional and molecular interactions between the gut microbiome and the human body to develop targeted therapeutics.Enterome is focused on the identification of the bioactive molecules that are differentially expressed, secreted and regulated by the gut microbiome, whichplay a central role in the regulation of key aspects of human physiology and the immune system. | $1.6M | Seed | Jan 01, 2011 | http://www.enterome.com |

2 of 2 investments shown.

## Co-investors
- [Auriga Partners](https://shizune.co/investors/profile/auriga-partners) — VC Fund, 1 deal together
- [Biocodex](https://shizune.co/investors/profile/biocodex) — VC Fund, 1 deal together
- [Cap Innov'Est](https://shizune.co/investors/profile/cap-innovest) — VC Fund, 1 deal together
- [Seventure Partners](https://shizune.co/investors/profile/seventure-partners) — VC Fund, 1 deal together
- [Sofimac Innovation](https://shizune.co/investors/profile/sofimac-innovation) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [Kima Ventures](https://shizune.co/investors/profile/kima-ventures) — VC Fund
- [Motier Ventures](https://shizune.co/investors/profile/motier-ventures) — VC Fund

## Featured in investor lists
- [Life Science Investors in France](https://shizune.co/investors/life-science-investors-france)
- [Life Science VC Funds in France](https://shizune.co/investors/life-science-vc-funds-france)

## FAQ

### What does INRA invest in?

INRA invests primarily in Biopharma, Health Care and Biotechnology startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact INRA?

Public channels for INRA include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at INRA?

The team at INRA includes Evelyne Lhoste (Team Member) and Joel Dore (Research Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co